Archives

Phase III Trial Enrollment Reached (75%) for Promising Anti-Inflammatory and Anti-Fibrotic Cardiac Therapies by Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL)

$CRDL Target Recruitment Anticipated by End of Q2 2026, with Potential to Extend into Q3 to Accommodate Enrollment from Additional Clinical Sites Late-Stage Life Sciences… Login to continue reading Login…

Read MorePhase III Trial Enrollment Reached (75%) for Promising Anti-Inflammatory and Anti-Fibrotic Cardiac Therapies by Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL)

Zhangjiagang Alps Machine Co., Ltd. Introduces Automated Mineral Water Filling Systems for Bottled Water Production

Integrated washing, filling, and capping technology supports efficient and hygienic beverage manufacturing. Zhangjiagang Alps Machine Co., Ltd., a professional manufacturer of beverage filling and packing… Login to continue reading Login…

Read MoreZhangjiagang Alps Machine Co., Ltd. Introduces Automated Mineral Water Filling Systems for Bottled Water Production